mail
admin@editorjprims.com
whatsapp
+919343055451
e-ISSN: 3049-1681
logo

Journal of Pharmaceutical Research and Integrated Medical Sciences

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2025

📢 Latest Update: New special issue call for papers on "Emerging Technologies in Research" - Submit by March 31, 2025

February 2025

Volume 2, Issue 2 - $2025

Volume 2 Issue 2 Cover

Issue Details:

Volume 2 Issue 2
Published:Invalid Date

Editorial: February 2025

Welcome to the 2025 issue of Journal of Pharmaceutical Research and Integrated Medical Sciences. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr. Arpan Kumar Tripathi
Editor-in-Chief
Journal of Pharmaceutical Research and Integrated Medical Sciences

Articles in This Issue

Showing 6 of 6 articles
Research PaperID: JPRIMS220030

Development of Orally Disintegrating Tablets for Paediatric and Geriatric Patients

Deepak Biswas, Vinay Sagar Verma

The present research on orally disintegrating tablets (ODTs) of pediatric and geriatric patients reviewed 10–15 secondary source formulations for disintegration time, mechanical strength, drug release, and taste-maskedness. Lyophilization yielded the shortest disintegration (5–15 sec) and maximum dissolution (85–95%) but exhibited poor mechanical strength (10–20N). Direct compression yielded the maximum strength (40–50N) but the maximum disintegration time (25–40 sec). Sublimation equilibrated both, with fair disintegration (15–30 sec) and hardness (20–35N) but required improved taste-masking. Statistical analysis revealed good negative correlation (-0.85) between dissolution time and dissolution rate. Regression analysis validated lyophilization effectively lowered disintegration time (p = 0.012, β = -0.74), whereas direct compression raised it (p = 0.031, β = +0.62). The research emphasizes lyophilization as the most efficient technique but proposes hybrid methods and AI-aided optimization for improved mechanical strength and taste-masking. Clinical validation and in-vivo testing should be included in future work.

Antimicrobial activity Bunchosia glandulifera (Jacq.) Kunth disc diffusion methodpathogenic organisms
2,872 views
841 downloads

Contributors:

 Deepak Biswas
,
 Vinay Sagar Verma
Research PaperID: JPRIMS220031

Formulation And Evaluation of Oral Suspension Containing Poorly Water-Soluble Drugs

Lukeshwari Sahu, Sandhya

Poor aqueous solubility is a critical issue in drug development, with implications on bioavailability and therapeutic activity. This research involves formulation and testing of an oral suspension of a poorly water-soluble drug with the aim of improving solubility, stability, and dissolution rates. A total of 20 formulations (F1–F20) were prepared employing different levels of suspending agents, surfactants, and stabilizers. All the formulations were evaluated in quintuplicate (n = 100) for physicochemical properties, in vitro dissolution profiles, and stability at various storage conditions. Formulations F10 and F15 exhibited maximum drug release (97.5% and 95.3% at 120 minutes, respectively) and best stability for 30 days, with negligible pH change and sedimentation volume ratio. Statistical comparison employing ANOVA validated enhanced solubility and dissolution of the drug compared with non-optimized formulations (p

Pediatric and Geriatric Formulations.Mechanical StrengthDrug ReleaseDisintegration TimeLyophilizationOrally Disintegrating Tablets
2,943 views
939 downloads

Contributors:

 Lukeshwari Sahu
,
 Sandhya
Research PaperID: JPRIMS220032

AI-Enabled Devices in Drug Discovery: Bridging the Gap Between Research and Clinical Application

Neha Mandle, Shahbaz Rathor

Artificial intelligence (AI) is transforming drug discovery by dramatically improving efficiency, lowering costs, and raising the rate of success. AI-powered algorithms scan enormous biological datasets, such as genomics and proteomics, to discover disease-related targets and forecast therapeutic interactions. This AI-supported process speeds up drug research, streamlining the drug development pipeline and heightening approval success rates. AI further helps predict pharmacokinetics, toxicity, and lead compound optimization, reducing costly and time-consuming experimental processes. In addition, AI-based systems assess real-world patients' data to offer personalized drug choices and optimize treatment effectiveness as well as compliance. This review exhaustively discusses AI applications in drug discovery, PK/PD studies, process optimization, and drug delivery dosage form development and raises related challenges as well as future directions for research.

stability studies.formulation optimizationdrug dissolutionsolubility enhancementoral suspensionPoorly water-soluble drugs
2,990 views
932 downloads

Contributors:

 Neha Mandle
,
 Shahbaz Rathor
Research PaperID: JPRIMS220033

Drug Delivery Methods Based on Nanoparticles for The Management ofCardiovascular Disorders

Harshalata Kanwar, Rashmi Chandra

Nanoparticle drug delivery systems have evolved as a revolutionary approach to the treatment of cardiovascular diseases (CVDs). These systems present a highly hopeful alternative to traditional drugs, which often have limited bioavailability, systemic toxicity, poor solubility, and a dearth of targeted therapeutic effect. Liposomal, polymeric, metallic, and dendrimer-based nanoparticles are just a few examples of nanoscale carriers that can deliver drugs to injured tissues in a targeted fashion. This facilitates controlled and sustained drug release while at the same time reducing off-targeting effects. Nanotechnology can potentially enhance therapeutic responses significantly by aiding in the stabilization of medication, circulation time, and cellular internalization. This, in turn, will help to reduce unwanted effects and enhance patient care. The application of nanoparticles in tissue engineering is not only limited to the delivery of drugs but also plays a critical role in the regeneration of heart tissue and function as good contrast agents for imaging purposes, allowing for real-time monitoring of diseases. However, despite their enormous promise, their widespread clinical use is hampered by obstacles such as the toxicity of nanoparticles, the quick clearance of the immune system, intricacy of manufacture on a large scale, and onerous regulatory approval procedures. The effective integration of nanoparticle therapeutics with traditional cardiovascular treatment will depend upon the successful solution of these issues through the creation of biocompatible materials, effective surface modifications, and scalable manufacturing processes. Under the purview of this research, the latest advances in drug delivery through nanotechnology are explored, the mechanisms by which therapeutic action is enhanced are explored, and the potential future directions for implementing these advances into cardiovascular therapy protocols are explored.

Clinical Application.AI-Enabled Drug Delivery SystemsPharmacodynamics (PD)Pharmacokinetics (PK)Drug DiscoveryArtificial Intelligence (AI)
3,126 views
1,060 downloads

Contributors:

 Harshalata Kanwar
,
 Rashmi Chandra
Research PaperID: JPRIMS220034

Nano Formulation Properties, Characterization, And Behaviour in Complex Biological Matrices: Challenges and Opportunities for Brain-Targeted Drug Delivery Applications

Hemkanti Patel, Harshalata Kanwar

Synthetic as well as cell-based nanocarriers have come into great consideration for treating neurodegenerative diseases as well as other cerebral conditions. How well the brain-targeting delivery of drugs happens using Nano formulations is hugely determined by the physicochemical parameters such as size, shape, hydrophobicity, elasticity, and charge/chemistry/morphology at the surface of the drug nanocarrier, which determines their mode of interaction with living systems. One of the key determinants of their in vivo behavior is the protein corona formation, which governs nanoparticle recognition, circulation, and biodistribution. It is important to understand the biological matrices and cell culture compositions involved in protein corona formation in order to design efficient nanomedicines. In addition, characterization of nanocarriers in complex biological environments poses specific challenges, and advanced analytical methods need to be developed and used. This review discusses the types and properties of brain-targeted nanocarriers, there in vivo interactions, and the characterization methods employed for them. We also discuss the strengths and weaknesses of existing analytical tools, the difficulties in applying these methods in a Good Manufacturing Practice (GMP) setting, and the promise of orthogonal complementary characterization methods. By overcoming these challenges, this review will offer the insights into how the translational value of nanomedicines in brain disorders can be improved.

Cardiovascular Treatment Strategies.NanotechnologyMetallicPolymericLiposomalNanoscale Carriers+6 more
3,459 views
987 downloads

Contributors:

 Hemkanti Patel
,
 Harshalata Kanwar
Research PaperID: JPRIMS220035

Nanomedicine In Cancer Therapy: Advances, Challenges, And Future Direction

Pratibha Sahu, Harshalata Kanwar

Cancer is a major global cause of death that requires new approaches to treatment outside the use of traditional chemotherapy, radiotherapy, and surgery. Nanomedicine, based on the application of nanoparticles (NPs) to targeted drug delivery, offers an exciting area of research for increased therapeutic benefits while reducing side effects. In this review, developments in nanotechnology-based drug delivery systems (DDSs) are discussed, focusing on their value in transcending multidrug resistance (MDR), improving bioavailability, and increasing the specificity of treatment. Several NP-based systems, such as liposomes, polymeric NPs, metal NPs, and quantum dots, are analyzed with respect to cancer therapy. Additionally, this paper addresses issues with clinical translation, including biocompatibility, toxicity, and regulatory issues. At last, upcoming trends and directions of future studies to optimize NP-based cancer treatments are presented.

Biological Matrices.Nanoparticle CharacterizationPhysicochemical PropertiesBlood-Brain Barrier (BBB)Protein CoronaNanocarriers+1 more
3,307 views
1,111 downloads

Contributors:

 Pratibha Sahu
,
 Harshalata Kanwar